Pineapple Express Cannabis (PNXP) Shares Outstanding (Weighted Average) (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Shares Outstanding (Weighted Average) came in at $39.2 million in Q4 2025, up 97.64% year-on-year from $19.8 million in Q4 2024, and up 49.1% quarter-over-quarter from $26.3 million in Q3 2025.
Pineapple Express Cannabis (PNXP) Shares Outstanding (Weighted Average) (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Shares Outstanding (Weighted Average) across 8 years of filings, most recently posting $39.2 million for Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $39.2 million, up 97.64% year-over-year; the trailing twelve-month figure through Oct 2025 was $39.2 million (up 97.64% YoY), and the FY2025 annual result was $19.8 million, down 2.3% from the prior year.
- Shares Outstanding (Weighted Average) came in at $39.2 million for Q4 2025 at Pineapple Express Cannabis, up from $26.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $39.2 million in Q4 2025 to a low of $3.6 million in Q1 2021.
- The 5-year median for Shares Outstanding (Weighted Average) is $19.8 million (2024), against an average of $14.8 million.
- Across the five-year window, Shares Outstanding (Weighted Average) surged 444.77% in 2023 and declined 2.5% in 2024, its largest moves.
- Pineapple Express Cannabis' Shares Outstanding (Weighted Average) stood at $3.7 million in 2021, then changed by 0.0% to $3.7 million in 2022, then soared by 444.77% to $20.3 million in 2023, then retreated by 2.5% to $19.8 million in 2024, then jumped by 97.64% to $39.2 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $39.2 million (Q4 2025), $26.3 million (Q3 2025), and $21.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Pineapple Express Cannabis | - | - | - | 39.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 39.20 Mn |
| Jul 31, 2025 | 26.29 Mn |
| Apr 30, 2025 | 21.86 Mn |
| Jan 31, 2025 | 19.83 Mn |
| Oct 31, 2024 | 19.84 Mn |
| Jul 31, 2024 | 19.84 Mn |
| Apr 30, 2024 | 19.83 Mn |
| Jan 31, 2024 | 20.30 Mn |
| Oct 31, 2023 | 20.34 Mn |
| Jul 31, 2023 | 20.34 Mn |
| Apr 30, 2023 | 20.30 Mn |
| Jan 31, 2023 | 19.00 Mn |
| Oct 31, 2022 | 3.73 Mn |
| Jul 31, 2022 | 3.73 Mn |
| Apr 30, 2022 | 3.73 Mn |
| Jan 31, 2022 | 3.73 Mn |
| Oct 31, 2021 | 3.73 Mn |
| Jul 31, 2021 | 3.73 Mn |
| Apr 30, 2021 | 3.73 Mn |
| Jan 31, 2021 | 3.58 Mn |